HeartBeam (BEAT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.44, +0.93% vs the prior close of $0.43.
- Volume 460.05K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BEAT rises 0.9% to $0.44. Closed at $0.44, +0.93% vs the prior close of $0.43. Day range $0.41–$0.44, opened at $0.43.
BEAT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BEAT rises 0.9% to $0.44
- Closed at $0.44, +0.93% vs the prior close of $0.43. Day range $0.41–$0.44, opened at $0.43.
- Volume was 460.05K shares, 0.1x its 50-day average of 9.15M — lighter than usual.
- Price is -4.9% vs its 50-day average ($0.46) and -54.8% vs its 200-day average ($0.97).
- 52-week range $0.35–$4.00; today's close sits at 2% of that range, 89.1% below the 52-week high.
Oct 15, 2026 — BEAT jumps 9.9% to $0.43
- Closed at $0.43, +9.92% vs the prior close of $0.39. Day range $0.40–$0.44, opened at $0.40.
- Volume was 1.22M shares, 0.1x its 50-day average of 9.13M — lighter than usual.
- Price is -6.1% vs its 50-day average ($0.46) and -55.7% vs its 200-day average ($0.97).
- 52-week range $0.35–$4.00; today's close sits at 2% of that range, 89.2% below the 52-week high.
Oct 14, 2026 — BEAT dips 2.2% to $0.39, 7 down days in a row
- Closed at $0.39, -2.24% vs the prior close of $0.40. Day range $0.38–$0.41, opened at $0.41.
- Volume was 986.50K shares, 0.1x its 50-day average of 9.12M — lighter than usual.
- Price is -14.8% vs its 50-day average ($0.46) and -60.1% vs its 200-day average ($0.98).
- 52-week range $0.35–$4.00; today's close sits at 1% of that range, 90.2% below the 52-week high.
- That makes 7 straight losses.
Oct 13, 2026 — BEAT slides 5.4% to $0.40, 6 down days in a row
- Closed at $0.40, -5.41% vs the prior close of $0.43. Day range $0.39–$0.41, opened at $0.41.
- Volume was 1.54M shares, 0.2x its 50-day average of 9.10M — lighter than usual.
- Price is -13.3% vs its 50-day average ($0.46) and -59.6% vs its 200-day average ($0.99).
- 52-week range $0.35–$4.00; today's close sits at 1% of that range, 89.9% below the 52-week high.
- That makes 6 straight losses.
Oct 12, 2026 — BEAT slides 11.5% to $0.43, 5 down days in a row
- Closed at $0.43, -11.46% vs the prior close of $0.48. Day range $0.42–$0.48, opened at $0.48.
- Volume was 1.40M shares, 0.2x its 50-day average of 9.08M — lighter than usual.
- Price is -8.7% vs its 50-day average ($0.47) and -57.8% vs its 200-day average ($1.01).
- 52-week range $0.35–$4.00; today's close sits at 2% of that range, 89.4% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — BEAT dips 1.8% to $0.48, 4 down days in a row
- Closed at $0.48, -1.84% vs the prior close of $0.49. Day range $0.47–$0.51, opened at $0.49.
- Volume was 1.51M shares, 0.2x its 50-day average of 9.05M — lighter than usual.
- Price is +2.8% vs its 50-day average ($0.47) and -52.8% vs its 200-day average ($1.02).
- 52-week range $0.35–$4.00; today's close sits at 3% of that range, 88.0% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — BEAT slides 9.9% to $0.49, 3 down days in a row
- Closed at $0.49, -9.94% vs the prior close of $0.54. Day range $0.49–$0.53, opened at $0.52.
- Volume was 3.60M shares, 0.4x its 50-day average of 8.98M — lighter than usual.
- Price is +4.6% vs its 50-day average ($0.47) and -52.5% vs its 200-day average ($1.03).
- 52-week range $0.35–$4.00; today's close sits at 4% of that range, 87.8% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — BEAT slides 7.0% to $0.54
- Closed at $0.54, -7.02% vs the prior close of $0.58. Day range $0.53–$0.62, opened at $0.59.
- Volume was 5.11M shares, 0.6x its 50-day average of 8.89M — lighter than usual.
- Price is +16.0% vs its 50-day average ($0.47) and -47.9% vs its 200-day average ($1.04).
- 52-week range $0.35–$4.00; today's close sits at 5% of that range, 86.4% below the 52-week high.
Oct 6, 2026 — BEAT slides 10.7% to $0.58 on 2.1x normal volume
- Closed at $0.58, -10.70% vs the prior close of $0.65. Day range $0.57–$0.64, opened at $0.62.
- Volume was 18.32M shares, 2.1x its 50-day average of 8.53M — unusually heavy trading.
- Price is +24.9% vs its 50-day average ($0.47) and -44.6% vs its 200-day average ($1.05).
- 52-week range $0.35–$4.00; today's close sits at 6% of that range, 85.4% below the 52-week high.
Oct 5, 2026 — BEAT jumps 50.3% to $0.65, a 1-month high on 899.6x normal volume
- Closed at $0.65, +50.34% vs the prior close of $0.44. Day range $0.60–$0.95, opened at $0.75.
- Volume was 404.24M shares, 899.6x its 50-day average of 449.36K — unusually heavy trading.
- Price is +40.2% vs its 50-day average ($0.47) and -38.7% vs its 200-day average ($1.07).
- 52-week range $0.35–$4.00; today's close sits at 8% of that range, 83.7% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — BEAT jumps 3.8% to $0.44 on 1.8x normal volume
- Closed at $0.44, +3.82% vs the prior close of $0.42. Day range $0.42–$0.45, opened at $0.43.
- Volume was 803.60K shares, 1.8x its 50-day average of 442.80K — unusually heavy trading.
- Price is -6.2% vs its 50-day average ($0.46) and -59.7% vs its 200-day average ($1.08).
- 52-week range $0.35–$4.00; today's close sits at 2% of that range, 89.1% below the 52-week high.
BEAT latest news & SEC filings
Every SEC filing by or about BEAT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 14, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 13, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$5.04M (prior year -$4.97M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.10 (prior year -$0.15) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jun 25, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade BEAT
- How much it moves: over the last 20 sessions the average daily move was 7.93% (largest 50.3%). That is a volatile stock.
- Liquidity: about 22.24M shares (≈$9.70M) trade per day on average.
- 52-week position: $0.44 vs a range of $0.35–$4.00 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Richard Ferrari bought 57,500 shares on Apr 16, 2026.
- Latest filings: 8-K Aug 14, 2026; 10-Q Aug 13, 2026; 8-K Aug 3, 2026.
- Share count: 56.35M shares outstanding (Aug 11, 2026), +64.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
BEAT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.43 | 0.44 | 0.41 | 0.44 | 460.05K |
| Oct 15, 2026 | 0.40 | 0.44 | 0.40 | 0.43 | 1.22M |
| Oct 14, 2026 | 0.41 | 0.41 | 0.38 | 0.39 | 986.50K |
| Oct 13, 2026 | 0.41 | 0.41 | 0.39 | 0.40 | 1.54M |
| Oct 12, 2026 | 0.48 | 0.48 | 0.42 | 0.43 | 1.40M |
| Oct 9, 2026 | 0.49 | 0.51 | 0.47 | 0.48 | 1.51M |
| Oct 8, 2026 | 0.52 | 0.53 | 0.49 | 0.49 | 3.60M |
| Oct 7, 2026 | 0.59 | 0.62 | 0.53 | 0.54 | 5.11M |
| Oct 6, 2026 | 0.62 | 0.64 | 0.57 | 0.58 | 18.32M |
| Oct 5, 2026 | 0.75 | 0.95 | 0.60 | 0.65 | 404.24M |
| Oct 2, 2026 | 0.43 | 0.45 | 0.42 | 0.44 | 803.60K |
| Oct 1, 2026 | 0.37 | 0.45 | 0.37 | 0.42 | 1.79M |
| Sep 30, 2026 | 0.37 | 0.38 | 0.36 | 0.37 | 153.40K |
| Sep 29, 2026 | 0.38 | 0.38 | 0.36 | 0.37 | 286.60K |
| Sep 28, 2026 | 0.36 | 0.38 | 0.36 | 0.37 | 484.50K |
| Sep 25, 2026 | 0.38 | 0.38 | 0.35 | 0.36 | 682.40K |
| Sep 24, 2026 | 0.39 | 0.40 | 0.36 | 0.38 | 681.10K |
| Sep 23, 2026 | 0.42 | 0.43 | 0.39 | 0.39 | 597.60K |
| Sep 22, 2026 | 0.44 | 0.45 | 0.43 | 0.43 | 522.70K |
| Sep 21, 2026 | 0.40 | 0.43 | 0.40 | 0.43 | 357.50K |
About HeartBeam
HeartBeam (BEAT) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in SANTA CLARA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1779372.
BEAT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Willem Elfrink | Director | Apr 16, 2026 |
| Richard Ferrari | Director | Apr 24, 2026 |
| Michael R Jaff | Director | Apr 16, 2026 |
| Kenneth Warwick Iii Nelson | Director | Mar 23, 2026 |
| Marga Ortigas-Wedekind | Director | Apr 16, 2026 |
| Mark E Strome | Director | Apr 16, 2026 |
| Branislav Vajdic | President | Jul 24, 2026 |
| Urioste George De | Director | Mar 23, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Tim Cruickshank | CFO | Jul 24, 2026 |
| Robert Paul Eno | President | Apr 16, 2026 |
| Kenneth Harry Persen | Chief Technology Officer | Jul 24, 2026 |
| Branislav Vajdic | President | Jul 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 16, 2026 | Richard Ferrari | Buy | 57,500 | $0.80 |
| Apr 16, 2026 | Richard Ferrari | Buy | 57,500 | $0.80 |
| Apr 16, 2026 | Richard Ferrari | Buy | 57,500 | $0.80 |
| Apr 16, 2026 | Richard Ferrari | Buy | 57,500 | $0.80 |
| Apr 16, 2026 | Michael R Jaff | Buy | 31,250 | $0.80 |
| Apr 16, 2026 | Michael R Jaff | Buy | 31,250 | $0.80 |
| Apr 16, 2026 | Michael R Jaff | Buy | 31,250 | $0.80 |
| Apr 16, 2026 | Michael R Jaff | Buy | 31,250 | $0.80 |
| Apr 16, 2026 | Robert Paul Eno | Buy | 12,500 | $0.80 |
| Apr 16, 2026 | Robert Paul Eno | Buy | 12,500 | $0.80 |
| Apr 16, 2026 | Robert Paul Eno | Buy | 12,500 | $0.80 |
| Apr 16, 2026 | Robert Paul Eno | Buy | 12,500 | $0.80 |
| Apr 16, 2026 | Mark E Strome | Buy | 750,000 | $0.80 |
| Apr 16, 2026 | Mark E Strome | Buy | 750,000 | $0.80 |
| Apr 16, 2026 | Mark E Strome | Buy | 750,000 | $0.80 |
BEAT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-21.02M | -0.62 | $-13.99M |
| Dec 31, 2024 | — | $-19.45M | -0.73 | $-14.47M |
| Dec 31, 2023 | — | $-14.64M | -0.72 | $-12.09M |
| Dec 31, 2022 | — | $-12.96M | -1.59 | $-9.95M |
| Dec 31, 2021 | — | $-4.43M | -1.03 | $-3.23M |
Latest balance sheet: total assets $10.64M, total liabilities $2.46M, cash $8.72M (as of Jun 30, 2026).
BEAT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BEAT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.